Ildong Pharmaceutical shows exceptional momentum with a 149% year to date return and a 145% one year gain. A P/E ratio near 31 is offset by a very low PEG ratio of 0.09, indicating strong value ...

Investing.com -- J.P. Morgan on Thursday shifted several European oil and gas ratings ahead of 2026, upgrading Norway’s Vår Energi and cutting Aker BP and Harbour Energy as it said weaker oil and gas ...

Investing.com -- Deutsche Bank cut its rating on Travis Perkins to “sell” from “buy,” citing continued weakness in the company’s core Merchanting division and a deteriorating backdrop for U.K.

Investing.com -- Schneider Electric (EPA:SCHN) will implement a share buyback program of up to €3.5 billion ($4.1 billion) through 2030, the French industrial group announced on Thursday. This marks ...

Investing.com -- Sanofi has received approval for two bleeding disorder treatments in China, expanding its hematology portfolio in the country. The French pharmaceutical company announced Thursday ...

Lens Technology intends to acquire 100% of PMG International, which holds a controlling stake in Zhejiang Yuanshi Technology, a supplier of server cabinets, structural components, and server ...

GENEVA, Dec 11 (Reuters) - Venezuela’s Bolivarian National Guard (GNB) committed serious human rights violations and crimes ...

The Fed on Wednesday delivered a 25-bp cut amid sharp divisions and dissents among central bank officials. New policymaker ...

Dec 11 (Reuters) - Asian equities witnessed their largest monthly foreign outflows in nearly six years in November, driven by ...

SEOUL, Dec 11 (Reuters) - South Korean battery maker SK On said on Thursday that it has decided to end its joint venture with Ford Motor for their joint battery factories in the United States. SK On ...

Investing.com -- Schott Pharma (ETR:1SXP) on Thursday reported fiscal 2025 revenue slightly below expectations and issued 2026 guidance that fell short of analyst forecasts.

Investing.com -- Munich Re on Thursday forecast €64 billion in insurance revenue for 2026, surpassing the €62 billion consensus and signaling a stronger top-line outlook than expected. The guidance ...